Observational study of patients with advanced basal cell carcinoma
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
This study looks at patients with advanced basal cell carcinoma to better understand their characteristics, how the disease progresses, and what treatments are available.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Academic / other |
| Locations | 1 site (Roma, ITA) |
| Trial ID | NCT06309836 on ClinicalTrials.gov |
What this trial studies
This study aims to investigate and characterize the profile of patients with advanced basal cell carcinoma (BCC), a common skin cancer. It will collect both retrospective and prospective data on patients diagnosed with advanced BCC, focusing on their clinical characteristics, disease progression, and treatment options. The study seeks to address the lack of accurate incidence data and improve understanding of this condition, which has seen an increase in cases and a younger average age of onset. By analyzing patient data from dermatology and oncology outpatient clinics, the study will provide valuable insights into the management of advanced BCC.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with advanced basal cell carcinoma who have accessed dermatology or oncology clinics.
Not a fit: Patients who are unable to provide informed consent or do not have advanced basal cell carcinoma will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of advanced BCC and improve treatment strategies for patients.
How similar studies have performed: While there have been studies on basal cell carcinoma, this specific observational approach focusing on advanced cases is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male and female patients aged ≥ 18 years 2. Patients diagnosed with advanced basal cell carcinoma of the skin, i.e. tumours included in at least one of the following categories: locally advanced carcinoma (not radically treatable by surgery and/or radiotherapy), carcinoma with lymph node and/or distant metastatic localisation 3. patients who have had at least one access (first visit or follow-up visit) at the dermatology or oncology outpatient clinic of the centres involved * Patients diagnosed with advanced BCC who have accessed the centre from 1 January 2016 until the date of activation of the centre will be included in the retrospective cohort; * Patients diagnosed with advanced BCC who have accessed the centre from the date of activation 4. Signature of informed consent Exclusion Criteria: Patients incapable of giving informed consent
Where this trial is running
Roma, ITA
- Irccs Fondazione Policlinico Gemelli — Roma, Ita, Italy (Recruiting)
Study contacts
- Principal investigator: Ketty MD Peris — Irccs Fondazione Policlinico Gemelli
- Study coordinator: Ketty MD Peris
- Email: ketty.peris@unicatt.it
- Phone: 0630154211
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.